GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Glenmark Pharmaceuticals Ltd.

NSE: GLENMARK | BSE: 532296 | ISIN: INE935A01035 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

1818.8000 -11.70 (-0.64%)

NSE Jul 09, 2025 15:31 PM

New 52W High in past week

Volume: 1.2M

Glenmark Pharmaceuticals Ltd.

21 Jan 2025

1818.80

-0.64%

Company Update

GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Glenmark Pharmaceuticals Inc. USA launches Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules

More from Glenmark Pharmaceuticals Ltd.

Recommended

Market closes lower, Sarda Energy gets CSPDCL nod to source power from Rehar-1 hydro project

Trendlyne Marketwatch | 09 Jul 2025, 05:47PM

All in the family: Bajaj, Murugappa, Mahindra & Tata Group stocks outpace the benchmark

The Baseline | 09 Jul 2025, 04:24PM

Earnings Call Transcript - Q4FY20 for Glenmark Pharmaceuticals